Eczemas in the elderly often arise mysteriously and itch furiously. New-onset, otherwise unexplained eczema that cannot be attributed to atopic disease, irritant or allergic contact dermatitis ...

Eczema is now a worldwide epidemic. In the UK up to one-fifth of school-age children and one in 12 adults suffer from it. It is itchy, painful and often unsightly, reduces the quality of life and ...

“The odds of eczema increased with greater PM2.5 concentration in our large, diverse, adult American cohort. Ambient air pollution is an environmental hazard that influences inflammatory skin ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Background Hand eczema is common in the general population and affects women twice as often as men. It is also the most frequent occupational skin disease. The economic consequences are ...

This article discusses the treatment options for severe eczema in adults and children. Individuals with eczema may experience mild symptoms. However, the condition can be chronic and cause ...

AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a ...

When conventional treatments for moderate to severe atopic dermatitis become less effective, targeted therapies may help.

The Medicines and Healthcare products Regulatory Agency has approved the medicine delgocitinib (Anzupgo) to treat severe ...

Eczema, which is also known as atopic dermatitis, can and does persist into adulthood for more than 16 million adults. If you first developed eczema in childhood, you may have learned to recognize ...

UK MHRA grants marketing authorization to Leo Pharma’s delgocitinib to treat adult patients with moderate to severe chronic hand eczema: United Kingdom Thursday, December 12, 20 ...